|
|
|
|
LEADER |
00000cam a2200000Mu 4500 |
001 |
EBOOKCENTRAL_ocn476041167 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr mn|---||||| |
008 |
091207s2006 inu o 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d MHW
|d OCLCQ
|d DEBSZ
|d OCLCQ
|d ZCU
|d MERUC
|d S8J
|d OCLCO
|d OCLCF
|d OCLCQ
|d ICG
|d OCLCQ
|d DKC
|d AU@
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCA
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|d OCLCL
|
020 |
|
|
|a 9780253112101
|q (electronic bk.)
|
020 |
|
|
|a 0253112109
|q (electronic bk.)
|
029 |
1 |
|
|a DEBBG
|b BV044123052
|
029 |
1 |
|
|a DEBSZ
|b 430379617
|
035 |
|
|
|a (OCoLC)476041167
|
043 |
|
|
|a n-us---
|
050 |
|
4 |
|a HD9666.5 .W43 2006eb
|
082 |
0 |
4 |
|a 174.96151
|a 174/.96151
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Weber, Leonard J.
|
245 |
1 |
0 |
|a Profits before People?.
|
260 |
|
|
|a Bloomington :
|b Indiana University Press,
|c 2006.
|
300 |
|
|
|a 1 online resource (225 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
520 |
|
|
|a In Profits before People? Leonard J. Weber exposes pharmaceutical industry practices that have raised ethical concerns. Providing systematic ethical analysis and reflection, he discusses such practices as compensating physicians for serving as speakers or consultants, providing incentives to physicians to enroll patients as subjects in clinical research, and advertising prescription drugs to the public through the mass media. His critique of the industry is stern. ''The profit motive can be a very powerful incentive, so powerful that it can, at times, distort a company's understanding of its t.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Cover; Contents; Acknowledgments; Introduction; PART ONE THE LIMITS OF COMMERCIAL INTERESTS; 1. Ethics and For-Profit Business; 2. The Pharmaceutical Industry and ItsStakeholders; PART TWO MARKETING TO HEALTHCARE PROFESSIONALS; 3. Drug Companies and HealthcareProfessionals:?e Ethics Agenda; 4. Medical Professionalism and ScientificIntegrity; 5. The Industry's Code: Not Good Enough; 6. Drug Samples:?e Most ImportantGifts; 7. Marketing Is Not Objective Education; 8. Medical Education: Industry at Arm'sLength; 9. Clinical Research and the Limits ofCommercial Interests.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Pharmaceutical industry
|x Moral and ethical aspects
|z United States.
|
650 |
|
0 |
|a Marketing
|x Moral and ethical aspects
|z United States.
|
650 |
|
0 |
|a Drugs.
|
650 |
1 |
2 |
|a Drug Industry
|x ethics
|
650 |
2 |
2 |
|a Drug Industry
|x economics
|
650 |
2 |
2 |
|a Marketing
|x ethics
|
650 |
2 |
2 |
|a Pharmaceutical Preparations
|
651 |
|
2 |
|a United States
|
650 |
|
6 |
|a Industrie pharmaceutique
|x Aspect moral
|z États-Unis.
|
650 |
|
6 |
|a Marketing
|x Aspect moral
|z États-Unis.
|
650 |
|
6 |
|a Médicaments.
|
650 |
|
7 |
|a Drugs
|2 fast
|
650 |
|
7 |
|a Marketing
|x Moral and ethical aspects
|2 fast
|
650 |
|
7 |
|a Pharmaceutical industry
|x Moral and ethical aspects
|2 fast
|
651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
758 |
|
|
|i has work:
|a Profits before people? (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFMkR3Y9HRphTgkFtttPDC
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
1 |
|
|z 9780253347480
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=288357
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL288357
|
994 |
|
|
|a 92
|b IZTAP
|